Binding Molecules For The Treatment Of Myeloid Cell Malignancies


The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.

Download PDF
Document Preview
Document History
  • Publication: Jun 22, 2010
  • Application: Dec 22, 2005
    US US 31778605 A
  • Priority: Jun 25, 2004
    EP EP 2004051243 W
  • Priority: Feb 9, 2004
    EP EP 2004050100 W
  • Priority: Jun 25, 2003
    EP EP 0350264 W

Download Citation

Sign in to the Lens